Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LTR Pharma Limited ( (AU:LTP) ) has shared an announcement.
LTR Pharma Limited has released its half-year report for the period ending December 31, 2024, in compliance with ASX listing requirements. The report includes the consolidated financial report and the Directors’ Report, providing stakeholders with insights into the company’s financial performance during this period.
More about LTR Pharma Limited
YTD Price Performance: -22.22%
Average Trading Volume: 649,717
Technical Sentiment Consensus Rating: Strong Buy
Find detailed analytics on LTP stock on TipRanks’ Stock Analysis page.